STADA Launches Anti-Cancer Drug Pemetrexed
(WorldNews Germany)

07/20/2018 - 11.00 AM . Press Release Bad Vilbel, July 20, 2018 - STADAPHARM GmbH, the subsidiary of STADA Arzneimittel AG focused on specialty pharmaceuticals, will from now on distribute cytostatic drug Pemetrexed STADA®. The drug is used for treating locally advanced, metastasized and non-small cell lung cancer and is a generic of the product Alimta® by Lilly. It generated global sales of around USD 2.06 billion in 2017. In Germany, this product most recently...